Depressive symptoms and metabolic risk: effects of cortisol and gender.
Standard
Depressive symptoms and metabolic risk: effects of cortisol and gender. / Muhtz, Christoph; Zyriax, Birgit-Christiane; Klähn, Tilman; Windler, Eberhard; Otte, Christian.
in: PSYCHONEUROENDOCRINO, Jahrgang 34, Nr. 7, 7, 08.2009, S. 1004-1011.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Depressive symptoms and metabolic risk: effects of cortisol and gender.
AU - Muhtz, Christoph
AU - Zyriax, Birgit-Christiane
AU - Klähn, Tilman
AU - Windler, Eberhard
AU - Otte, Christian
PY - 2009/8
Y1 - 2009/8
N2 - We examined gender effects and the role of cortisol in the association between depressive symptoms and metabolic risk in the Stress, Atherosclerosis, and ECG Study (STRATEGY). In 215 healthy adults from the general population (n=107 men, n=108 women, distributed equally across four age groups, 30-70 years), we assessed depressive symptoms by the Patient Health Questionnaire (PHQ score >10) and measured variables of the metabolic syndrome: high-density lipoprotein (HDL), triglycerides, systolic and diastolic blood pressure, fasting blood glucose and waist circumference. Salivary cortisol was assessed at 08:00, 12:00, 16:00 and 22:00 h. Depressive symptoms were not associated with the metabolic syndrome as entity in the total sample or in men and women separately. However, women with depressive symptoms had larger waist circumferences, higher fasting blood glucose, lower HDL-cholesterol, higher diastolic blood pressure, and higher 16:00 and 22:00 h salivary cortisol compared to women without depressive symptoms. These results persisted after adjusting for age, education, smoking, and physical activity. In adjusted regression analyses, inclusion of cortisol attenuated the association between depressive symptoms and waist, fasting glucose, HDL and diastolic blood pressure in women. In men, we did not find an association between depressive symptoms and variables of the metabolic syndrome. In women, depressive symptoms are associated with several variables of the metabolic syndrome. Elevated afternoon and evening cortisol appear to partially mediate this association.
AB - We examined gender effects and the role of cortisol in the association between depressive symptoms and metabolic risk in the Stress, Atherosclerosis, and ECG Study (STRATEGY). In 215 healthy adults from the general population (n=107 men, n=108 women, distributed equally across four age groups, 30-70 years), we assessed depressive symptoms by the Patient Health Questionnaire (PHQ score >10) and measured variables of the metabolic syndrome: high-density lipoprotein (HDL), triglycerides, systolic and diastolic blood pressure, fasting blood glucose and waist circumference. Salivary cortisol was assessed at 08:00, 12:00, 16:00 and 22:00 h. Depressive symptoms were not associated with the metabolic syndrome as entity in the total sample or in men and women separately. However, women with depressive symptoms had larger waist circumferences, higher fasting blood glucose, lower HDL-cholesterol, higher diastolic blood pressure, and higher 16:00 and 22:00 h salivary cortisol compared to women without depressive symptoms. These results persisted after adjusting for age, education, smoking, and physical activity. In adjusted regression analyses, inclusion of cortisol attenuated the association between depressive symptoms and waist, fasting glucose, HDL and diastolic blood pressure in women. In men, we did not find an association between depressive symptoms and variables of the metabolic syndrome. In women, depressive symptoms are associated with several variables of the metabolic syndrome. Elevated afternoon and evening cortisol appear to partially mediate this association.
KW - Adult
KW - Age Factors
KW - Aged
KW - Blood Glucose
KW - Blood Pressure
KW - Cholesterol, HDL/blood
KW - Circadian Rhythm
KW - Depression/complications
KW - Female
KW - Humans
KW - Hydrocortisone/metabolism
KW - Male
KW - Metabolic Syndrome/etiology
KW - Middle Aged
KW - Risk Factors
KW - Saliva/chemistry
KW - Sex Characteristics
KW - Triglycerides/blood
KW - Waist Circumference
U2 - 10.1016/j.psyneuen.2009.01.016
DO - 10.1016/j.psyneuen.2009.01.016
M3 - SCORING: Journal article
C2 - 19278789
VL - 34
SP - 1004
EP - 1011
JO - PSYCHONEUROENDOCRINO
JF - PSYCHONEUROENDOCRINO
SN - 0306-4530
IS - 7
M1 - 7
ER -